XML 14 R3.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Statement of Comprehensive Income [Abstract]        
Product revenue, net $ 207,638 $ 182,546 $ 559,282 $ 493,150
Operating expenses:        
Cost of sales 4,596 2,867 10,432 7,926
Research and development 68,846 59,336 190,052 176,587
Selling, general and administrative 123,977 73,745 318,488 196,948
Total operating expenses 197,419 135,948 518,972 381,461
Income from operations 10,219 46,598 40,310 111,689
Interest and other income 5,024 6,345 16,243 17,844
Income before income taxes 15,243 52,943 56,553 129,533
Income tax benefit (expense) 4,425 (5,730) 18,811 (19,070)
Net income 19,668 47,213 75,364 110,463
Net income attributable to common stockholders basic 19,359 46,690 74,267 109,344
Net income attributable to common stockholders diluted $ 19,359 $ 46,690 $ 74,267 $ 109,344
Basic net income per common share (in dollars per share) $ 0.19 $ 0.45 $ 0.71 $ 1.06
Diluted net income per common share (in dollars per share) $ 0.16 $ 0.41 $ 0.62 $ 0.98
Weighted-average shares outstanding used in computing net income per common share        
Basic (in shares) 103,545 103,371 103,919 103,094
Diluted (in shares) 119,439 113,723 119,981 111,571